Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder

Producción científica: Articlerevisión exhaustiva

62 Citas (Scopus)

Resumen

The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.

Idioma originalEnglish (US)
Páginas (desde-hasta)127-132
Número de páginas6
PublicaciónJournal of the American Academy of Child and Adolescent Psychiatry
Volumen26
N.º2
DOI
EstadoPublished - 1987

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Huella

Profundice en los temas de investigación de 'Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder'. En conjunto forman una huella única.

Citar esto